CIK 0001705843
- Non-accelerated filer
- Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271967997
- Phone
- +1 858-450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-27 | Dumont Philippe Director | Grant or award · Stock Option (Right-to-Buy) | +10,291 | 10,291 | ||
| 2021-05-12 | NEUGENT CHRISTOPHER J Director | Purchase | +15,000 | $3.95 | $59K | 15,000 |
| 2021-05-03 | Ribeill Yves J Executive Chair | Grant or award | +9,430 | 56,051 | ||
| 2021-04-01 | Ribeill Yves J Director | Grant or award | +16,591 | 46,621 | ||
| 2021-03-12 | Frey Travis Chief Technology Officer | Grant or award | +16,500 | 19,400 | ||
| 2021-03-12 | Frey Travis Chief Technology Officer | Grant or award · Stock Option (Right-to-Buy) | +24,000 | 24,000 | ||
| 2021-03-12 | Frimerman Debra H General Counsel and Secretary | Grant or award | +19,000 | 19,000 | ||
| 2021-03-12 | Frimerman Debra H General Counsel and Secretary | Grant or award · Stock Option (Right-to-Buy) | +27,000 | 27,000 | ||
| 2021-03-12 | Koschak William Chief Financial Officer | Grant or award | +18,000 | 18,000 | ||
| 2021-03-12 | Koschak William Chief Financial Officer | Grant or award · Stock Option (Right-to-Buy) | +26,000 | 26,000 | ||
| 2021-03-12 | NEUGENT CHRISTOPHER J Director | Grant or award | +5,000 | 7,940 | ||
| 2021-03-12 | NEUGENT CHRISTOPHER J Director | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2021-03-12 | Koschak William Chief Financial Officer | Grant or award · Stock Option (Right-to-Buy) | +26,000 | 26,000 | ||
| 2021-03-12 | Koschak William Chief Financial Officer | Grant or award · Restricted Stock Units | +18,000 | 18,000 | ||
| 2021-03-12 | Frimerman Debra H General Counsel and Secretary | Grant or award · Stock Option (Right-to-Buy) | +27,000 | 27,000 | ||
| 2021-03-12 | Frimerman Debra H General Counsel and Secretary | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2021-03-12 | Frey Travis Chief Technology Officer | Grant or award · Stock Option (Right-to-Buy) | +24,000 | 24,000 | ||
| 2021-03-12 | Frey Travis Chief Technology Officer | Grant or award · Restricted Stock Units | +16,500 | 16,500 | ||
| 2021-01-04 | Voytas Daniel F Chief Science Officer | Sale | −2,513 | $4.13 | $10K | 0 |
| 2020-12-31 | Blome James Chief Executive Officer | Sale | −4,140 | $4.17 | $17K | 186,282 |
Page 18 of 19 · 365 trades